Hugh Piercy
Research Officer, Clinical and Social Research Team, Turning Point and Monash University
Overview
Hugh has experience delivering cognitive bias modification (CBM) training to alcohol and methamphetamine dependent populations across a number of withdrawal treatment settings in Melbourne, and he is interested in the development of novel neurocognitive and pharmacological treatments for addiction.
In his current role, he is involved in the development and trialling of a novel cognitive bias modification smartphone app called the “approach-avoidance training app”, or “AAT-App”, for short. He is also working on an NHMRC-funded clinical trial which aims to test the effectiveness of vaporised nicotine devices for smoking cessation among substance-dependent populations. Hugh has written and co-authored a number of papers on neurocognitive interventions and smoking cessation, accruing over 50 citations in the past two years of his career.
Background
Hugh completed his Honours in Psychology at Monash University in 2018, and is currently employed as a research officer at Monash University’s Eastern Health Clinical School, based at Turning Point.
Research Interest
- Neurocognitive interventions
- Pharmacological treatments
- Clinical trials
- Mixed-methods research.